Results showed that in comparison to patients without cardiac events, BNP levels were significantly higher before and after every cycle of anthracycline in patients who experienced cardiac events (defined as asymptomatic LV dysfunction, symptomatic heart failure, symptomatic arrhythmia, acute coronary syndrome, or sudden cardiac death). The gene discussed is NPPB; the disease is acute coronary syndrome.